The FDA has approved ProlivRx, the first prescription, home-based brain neuromodulation therapy, as an adjunctive treatment ...

At booth #115, Integer will spotlight its latest advancements in neuromodulation and next-generation miniaturized active implantable medical devices (AIMDs). These innovations are designed to ...

Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today ...

The FDA approved a prescription at-home brain neuromodulation therapy as an adjunctive depression treatment for adults, maker ...

This approval represents a significant regulatory milestone, making Proliv™Rx the first and only at-home neuromodulation ...

ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced a landmark clinical research collaboration to evaluate precision radiomodulation therapy for ...

The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.

Neurolief announced today that the FDA granted approval for its Proliv Rx at-home neuromodulation therapy for treating ...

For individuals with major depressive disorder (MDD) that does not respond to pharmacotherapy, recent decisions by the U.S.

Spiro Medical, Inc., a Newco established to develop the first of its kind Pulmonary Neuromodulation System (PNM) for the ...

The clinical trial is expected to enroll up to 40 patients in two stages: an initial open-label pilot (10 patients) followed by a randomized, double-blinded, sham-controlled trial (30 patients).

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...